REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
05/25/2026
Back to search
Official data from USPTO
RED INDEX REAL ESTROGEN DOMINANCE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
RED INDEX REAL ESTROGEN DOMINANCE
ST13
US500000088625652Class
44
Filing
88625652
Registration
6365219
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
24
Latest update
05/26/2026
Trademark type
Word
Nice classes
44
Filing date
09/20/2019
Registration date
05/25/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/25/2021
Last transaction
05/26/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
First use anywhere
03/04/2021
First use in commerce
03/04/2021
Drawing code
4
Owner type
01
Owner location
Kecskemét, HU
Examiner
FOX III, LYAL L
Law office
M40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Pusztai, Dr. Zoltán
Representatives
Gregory B. Phillips KNOBBE, MARTENS, OLSON & BEAR, LLP
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Medical services; Health assessment services featuring conducting health surveys; Providing health information; Professional consultancy in the field of health; Health counselling; Medical serviceshealth care consultancy services; Health assessment services featuring conducting health surveys to assess health risks; Health screening in the field of hormonal imbalances; Health advice and information services; Laboratory analysis services relating to the treatment of personsmedical analysis services for diagnostic and treatment purposes provided by medical laboratories; Therapy serviceshormone therapy; Telemedicine services
Publications
History of USPTO decisions and trademark events.
24 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/25/2021
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04/20/2021
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04/17/2021
SUPC
STATEMENT OF USE PROCESSING COMPLETE
04/17/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
04/17/2021
IUAF
USE AMENDMENT FILED
04/01/2021
EISU
TEAS STATEMENT OF USE RECEIVED
04/01/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
10/06/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/11/2020
PUBO
PUBLISHED FOR OPPOSITION
08/11/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/22/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/07/2020
DOCK
ASSIGNED TO EXAMINER
06/29/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/27/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/27/2020
ALIE
ASSIGNED TO LIE
06/23/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/12/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/31/2019
GNRT
NON-FINAL ACTION E-MAILED
12/31/2019
CNRT
NON-FINAL ACTION WRITTEN
12/31/2019
DOCK
ASSIGNED TO EXAMINER
12/19/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/26/2019
NWAP
NEW APPLICATION ENTERED
09/24/2019
Continuous trademark protection
Get notified about every new filing that threatens RED INDEX REAL ESTROGEN DOMINANCE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.